🇺🇸 FDA
Patent

US 8999638

Method of treatment based on polymorphisms of the KCNQ1 gene

granted A61KA61K31/454A61K31/496

Quick answer

US patent 8999638 (Method of treatment based on polymorphisms of the KCNQ1 gene) held by VANDA PHARMACEUTICALS INC. expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VANDA PHARMACEUTICALS INC.
Grant date
Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/454, A61K31/496, A61K31/519, A61P